Anisha B. Patel, M.D.

Anisha B. Patel, M.D., is a Senior Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on clinical dermatology, oncology, and immunotherapy, with a specific emphasis on cutaneous immune-related adverse events (irAEs) induced by immune checkpoint inhibitors. Her recent work has identified the HLA-B*51:01 allele as a risk factor for these events in melanoma patients, characterized their histologic and immune features, and provided inference-based treatment guidance for immunotherapy-induced psoriasis. She has also investigated systemic toxicities, including hyperglycemia and diabetic ketoacidosis, associated with enfortumab vedotin, and adverse outcomes in urothelial cancer treatment. Her publications appear in venues such as *Cancer*, the *Journal of Clinical Oncology*, and the *Journal for ImmunoTherapy of Cancer*.